REG - Spirit Biosciences Mural Oncology PLC - Spirit Biosciences Cap Form 8.3 Mural Oncology plc

Mural OncologyAnnouncement

08/05/2025 07:01

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250508:nRSH7793Ha&default-theme=true

RNS Number : 7793H  Spirit Biosciences Capital LLC  07 May 2025

 
FORM 8.3

IRISH TAKEOVER PANEL

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER

RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT

SECURITIES REPRESENTING 1% OR MORE

1.          KEY INFORMATION

 

 (a)  Full name of discloser                                                       Spirit Biosciences Capital LLC
 (b) Owner or controller of interests and short positions disclosed, if
 different from 1(a)

 The naming of nominee or vehicle companies is insufficient. For a trust, the
 trustee(s), settlor and beneficiaries must be named.
 (c)  Name of offeror/offeree in relation to whose relevant securities this        Mural Oncology plc
 form relates

 Use a separate form for each offeror/offeree
 (d) If an exempt fund manager connected with an offeror/offeree, state this
 and specify identity of offeror/offeree (Note 1)
 (e)  Date position held/dealing undertaken                                        15(th) April 2025

 For an opening position disclosure, state the latest practicable date prior to
 the disclosure
 (f)  In addition to the company in 1(c) above, is the discloser also making       NO
 disclosures in respect of any other party to the offer?

 If it is a cash offer or possible cash offer, state "N/A"

 

2.          INTERESTS AND SHORT POSITIONS

If there are interests and short positions to disclose in more than one class
of relevant securities of the offeror or offeree named in 1(c), copy table 2
for each additional class of relevant security.

 

Interests and short positions in the relevant securities of the offeror or
offeree to which the disclosure relates following the dealing (if any) (Note
2)

 

 Class of relevant security (Note 3)                                     Ordinary shares of US$0.01 each
                                                                        Interests             Short positions
                                                                        Number     %          Number     %
 (1)  Relevant securities owned and/or controlled                        382,423    2.1
 (2)  Cash-settled derivatives
 (3)  Stock-settled derivatives (including options) and agreements to
 purchase/ sell
 Total                                                                   382,423    2.1

 

All interests and all short positions should be disclosed.

Details of options including rights to subscribe for new securities and any
open stock-settled derivative positions (including traded options), or
agreements to purchase or sell relevant securities, should be given on a
Supplemental Form 8.

3.          DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
(Note 4)

Where there have been dealings in more than one class of relevant securities
of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as
appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

 

 Class of relevant security         Purchase/sale  Number of securities  Price per unit (Note 5)
 Ordinary shares of US$0.01 each     Purchase       382,682              Average price per unit (over 1,441 individual trades):  US$2.41

                                                                          Minimum price per unit (over 1,441 individual trades):  US$2.05

                                                                          Maximum price per unit (over 1,441 individual trades):  US$2.89

  Ordinary shares of US$0.01 each    Sale           200                   US$2.75
  Ordinary shares of US$0.01 each    Sale           59                    US$2.75

(b)        Cash-settled derivative transactions

 

 Class of   Product       Nature of dealing                                                             Number of             Price

 relevant   description   e.g. opening/                                                                 reference             per unit

 security   e.g. CFD      closing a long/ short position, increasing/ reducing a long/ short position   securities (Note 6)   (Note 5)

 

(c)        Stock-settled derivative transactions (including options)

(i)       Writing, selling, purchasing or varying

 

 Class of   Product description e.g. call option  Writing, purchasing, selling, varying etc.  Number of securities to which option relates  Exercise price per unit  Type                          Expiry date  Option money paid/ received per unit

relevant

security                                                                                    (Note 6)                                                               e.g. American, Europeanetc.

 

(ii)      Exercise

 

 Class of   Product description e.g. call option  Exercising/ exercised against  Number of securities  Exercise price per unit (Note 5)

relevant

security

 

 

 

(d)        Other dealings (including transactions in respect of new
securities) (Note 3)

 

 Class of   Nature of dealing e.g. subscription, conversion, exercise  Details  Price per unit (if applicable) (Note 5)

relevant

security

4.                   OTHER INFORMATION

(a)         Indemnity and other dealing arrangements

 Details of any indemnity or option arrangement, or any agreement or
 understanding, formal or informal, relating to relevant securities which may
 be an inducement to deal or refrain from dealing entered into by the person
 making the disclosure and any party to the offer or any person acting in
 concert with a party to the offer.

 Irrevocable commitments and letters of intent should not be included. If there
 are no such agreements, arrangements or understandings, state "none"
 None

(b)         Agreements, arrangements or understandings relating to
options or derivatives

 Full details of any agreement, arrangement or understanding between the person
 disclosing and any other person relating to the voting rights of any relevant
 securities under any option referred to on this form or relating to the voting
 rights or future acquisition or disposal of any relevant securities to which
 any derivative referred to on this form is referenced. If none, this should be
 stated.

(c)         Attachments

 Is a Supplemental Form 8 attached?  No

 

 

 

 

 Date of disclosure  May 7, 2025
 Contact name        Zachary Malkin
 Telephone number    +1 630-318-0633

Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory
Information Service.

 

 

 

NOTES ON FORM 8.3

1.      See the definition of "connected fund manager" in Rule 2.2 of
    Part A of the Rules.

2.      See the definition of "interest in a relevant security" in Rule
2.5      of Part A of the Rules and see Rule 8.6(a) and (b) of Part B of
          the Rules.

3.      See the definition of "relevant securities" in Rule 2.1 of Part A
of the Rules.

4.      See the definition of "dealing" in Rule 2.1 of Part A of the
Rules.

5.      If the economic exposure to changes in the price of securities is
limited, for example, by virtue of a stop loss arrangement relating to a
spread bet, full details must be given.

6.      See Rule 2.5(d) of Part A of the Rules.

7.      If details included in a disclosure under Rule 8 are incorrect,
they should be corrected as soon as practicable in a subsequent disclosure.
Such disclosure should state clearly that it           corrects
details disclosed previously, identify the disclosure           or
disclosures being corrected, and provide sufficient detail for    the
reader to understand the nature of the corrections. In the case of any doubt,
the Panel should be consulted.

For full details of disclosure requirements, see Rule 8 of the Rules.
            If in doubt, consult the Panel.

References in these notes to "the Rules" are to the Irish Takeover Panel Act,
1997, Takeover Rules, 2022.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ITPUPUQPAUPAGRM